Painful Bilateral Ovarian Cysts

Clinical Case Study: Addressing Painful Bilateral Ovarian Cysts with coMra Therapy

In this clinical report, we examine the successful application of the Delta 905 laser device in treating a patient suffering from painful bilateral ovarian cysts. For the past four years, the patient had experienced chronic abdominal pain, consistently rating her discomfort at an eight out of ten – where ten represents the worst imaginable pain. She described the sensation as radiating and cramping, occurring intermittently throughout the month but becoming continuous during her menses.

Beyond the pain, the patient’s menstrual cycle had become significantly prolonged, lasting ten to twelve days rather than the typical three to five. This condition severely impaired her sleep, necessitating the use of a natural sleep aid, "Somnapure." Additionally, she suffered from chronic constipation, for which she relied on Dulcolax. Her medical history also included long-term use of Ativan to manage associated depression.

The Treatment Protocol

The clinical approach involved a multi-faceted strategy. Dr. Bernard Brom, who conducted the patient’s assessment, selected a homeopathic remedy tailored to her specific symptomatology. To address her neurological and emotional state, he incorporated microcurrent therapy, specifically utilizing the "Brain Balance" protocol to support the patient’s management of depression and medication use.

The core of the treatment utilized the Delta 905 laser. The protocol consisted of: * Treatment Schedule: Treatments were administered every second day for a total of 12 sessions, followed by a 10-day break, and then an additional 6 sessions. * Local Application: The Delta 905 was set to the 10-minute mode and applied directly to the uterine area. The device was moved periodically from point to point to ensure comprehensive coverage of the affected region. * Systemic Support: In accordance with coMra therapy principles, the practitioner implemented a "Universal 5" protocol alongside treatment of the carotid arteries to provide systemic support to the body while addressing the local area of concern.

Clinical Outcomes and Recovery

The results following the initial 12 treatments were significant. The patient reported a reduction in pain from an eight out of ten to a two out of ten, with discomfort becoming negligible except for minor symptoms immediately preceding her menses.

Following the 10-day break and the subsequent 6 treatments, further improvements were observed: * Sleep and Medication: The patient’s sleep quality improved significantly, allowing her to discontinue the use of Somnapure. Furthermore, a collaborative plan was established with her general practitioner to gradually taper off her other medications, including Ativan, as her healing progressed. * Digestive Health: The patient was able to stop taking Dulcolax. The treatment of the uterine area provided a secondary benefit to the intestines, leading to a marked improvement in her overall digestion. * Menstrual Cycle: Her cycle normalized, returning to a healthy duration of four to five days. * Objective Findings: Ultrasound reports confirmed a physical reduction in the size of the ovarian cysts – a 38% reduction on the left side and a 30% reduction on the right.

Currently, the patient is taking a scheduled break from the therapy, after which she will commence another course of ten treatments to continue her progress.